Gisely C. Melo

Manaus, AM, Brazil

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 65 publications

Dihydroartemisinin-piperaquine versus chloroquine for the treatment of uncomplicated Plasmodium vivax malaria with concurrent or delayed high-dose primaquine in Brazil (Curavivax): an open-label, single-centre, randomised clinical trial.

Dihydroartemisinin-piperaquine versus chloroquine for the treatment of uncomplicated Plasmodium vivax malaria with concurrent or delayed high-dose primaquine in Brazil (Curavivax): an open-label, single-centre, randomised clinical trial.

Journal: The Lancet. Infectious diseases

Published: October 06, 2025

Effectiveness of CoronaVac in a pioneer risk-based allocation clinical trial during the COVID-19 pandemic.

Effectiveness of CoronaVac in a pioneer risk-based allocation clinical trial during the COVID-19 pandemic.

Journal: PloS one

Published: September 01, 2025

Impact of obesity on COVID-19 CoronaVac and ChAdOx1-S vaccine efficacy.

Impact of obesity on COVID-19 CoronaVac and ChAdOx1-S vaccine efficacy.

Journal: BMC infectious diseases

Published: August 26, 2025

Safety, tolerability, and efficacy of high versus low-dose, short versus long-course daily primaquine for the radical cure of uncomplicated Plasmodium vivax malaria in children under 15 years of age: an open-label, non-inferiority, randomized controlled trial (CHILDPRIM).

Safety, tolerability, and efficacy of high versus low-dose, short versus long-course daily primaquine for the radical cure of uncomplicated Plasmodium vivax malaria in children under 15 years of age: an open-label, non-inferiority, randomized controlled trial (CHILDPRIM).

Journal: Malaria journal

Published: August 14, 2025

Predicted future climate scenarios impact survival and immune response but not Plasmodium vivax infection in Anopheles aquasalis (Diptera, Culicidae), the primary vector of coastal Central and South America and the Caribbean Islands.

Predicted future climate scenarios impact survival and immune response but not Plasmodium vivax infection in Anopheles aquasalis (Diptera, Culicidae), the primary vector of coastal Central and South America and the Caribbean Islands.

Journal: Acta tropica

Published: August 01, 2025

Classic and new candidate markers for drug resistance in a large cohort of leprosy patients from the Amazon state, Brazil.

Classic and new candidate markers for drug resistance in a large cohort of leprosy patients from the Amazon state, Brazil.

Journal: Antimicrobial agents and chemotherapy

Published: May 20, 2025

Metabolic disruptions in P. vivax malaria: Insights from four antimalarial treatment regimens.

Metabolic disruptions in P. vivax malaria: Insights from four antimalarial treatment regimens.

Journal: Acta tropica

Published: March 28, 2025

Safety and Efficacy of 3 Alternative Regimens Against Relapsing Plasmodium vivax Malaria in Glucose 6-Phosphate Dehydrogenase-Deficient Patients in the Brazilian Amazon (ALTPRIM).

Safety and Efficacy of 3 Alternative Regimens Against Relapsing Plasmodium vivax Malaria in Glucose 6-Phosphate Dehydrogenase-Deficient Patients in the Brazilian Amazon (ALTPRIM).

Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Published: September 19, 2024

A spatially resolved single-cell lung atlas integrated with clinical and blood signatures distinguishes COVID-19 disease trajectories.

A spatially resolved single-cell lung atlas integrated with clinical and blood signatures distinguishes COVID-19 disease trajectories.

Journal: Science translational medicine

Published: September 11, 2024

Author Correction: Impact of Plasmodium vivax malaria on executive and cognitive functions in elderlies in the Brazilian Amazon.

Author Correction: Impact of Plasmodium vivax malaria on executive and cognitive functions in elderlies in the Brazilian Amazon.

Journal: Scientific reports

Published: January 11, 2024

Spatially resolved single-cell atlas unveils a distinct cellular signature of fatal lung COVID-19 in a Malawian population.

Spatially resolved single-cell atlas unveils a distinct cellular signature of fatal lung COVID-19 in a Malawian population.

Journal: Nature medicine

Published: November 10, 2023

Methylprednisolone therapy induces differential metabolic trajectories in severe COVID-19 patients.

Methylprednisolone therapy induces differential metabolic trajectories in severe COVID-19 patients.

Journal: mSystems

Published: October 24, 2023

Showing 1-12 of 65

Last Updated: 09/26/2026